In vitro drug release from chitosan/Cloisite 15A hydrogels

Applied Clay Science

Volumn 57, Issue , 2012, Pages 1-9

  Cojocariu, Anca ^a   Profire, Lenuta ^b   Aflori, Magdalena ^a   Vasile, Cornelia ^a  

^a PETRU PONI INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Romania)

^b GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Chitosan; Closite 15A; Hydrogels; Kinetics; NO donors; Release

Indexed keywords

ACIDIC MEDIA; ANTI-INFLAMMATORY ACTIVITY; BIOCOMPOSITE; CLOISITE; CLOSITE 15A; CONTROLLED RELEASE; DRUG CARRIER; DRUG RELEASE; GASTRIC FLUIDS; GLUTARALDEHYDES; IN-VITRO; INTERCALATED STRUCTURES; MATRIX; NANOCOMPOSITE HYDROGELS; NITRIC OXIDE DONOR; NO DONORS; PARACETAMOL; PHARMACEUTICAL FIELDS; RELEASE; RELEASE MECHANISM;

ALDEHYDES; CHITOSAN; CLAY MINERALS; ENZYME KINETICS; HYDROGELS; NANOCOMPOSITES; NITRIC OXIDE; NITROGEN OXIDES; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

DRUG PRODUCTS;

ACIDITY; CONCENTRATION (COMPOSITION); DRUG; EXPERIMENTAL STUDY; GEL; MONTMORILLONITE; REACTION KINETICS; SCANNING ELECTRON MICROSCOPY; SWELLING; X-RAY DIFFRACTION;

EID: 84857046928     PISSN: 01691317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clay.2011.11.030     Document Type: Article

References (64)

1. Bhat G., Hedge R.R., Kamath M.G., Deshpande B. Nanoclay reinforced fibers and nonwomens. Journal of Engineered Fibers and Fabrics 2008, 3(3):22-23.
2. Cheaburu C.N., Stoica B., Neamţu A., Vasile C. Biocompatibility Tests of Chitosan Hydrogels. Revista Medico-Chirurgicala a Societatii de Medici si Naturalisti din Iasi. 2011, 115(3):864-866.
3. Costa P., Sousa Lobo J.M. Evaluation of mathematical models describing drug release from estradiol transdermal systems. Drug Development and Industrial Pharmacy 2003, 29:89-97.
4. Cypes S.H., Saltzman W.M., Giannelis E.P. Organosillicate-polymer drug delivery systems: controlled release and enhanced mechanical properties. Journal of Controlled Release 2003, 90:163-169.
5. Danilǎ Gh., Profire L., Bumbu G.G., Vasile C. Thermal characterization of some new xanthine derivatives. Thermochimica Acta 2000, 343(1-2):69-79.
6. de la Torre P.M., Torrado S., Torrado S. Interpolymer complexes of poly(acrylic acid) and chitosan: influence of the ionic hydrogel-forming medium. Biomaterials 2003, 24(8):1459-1468.
7. Depan D., Kumar A.P., Singh R.P. Cell proliferation and controlled drug release studies of nanohybrids based on chitosan-g-lactic acid and montmorillonite. Acta Biomaterialia 2009, 5(1):93-100.
8. Dong Y., Feng S.S. Poly (d, l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Biomaterials 2005, 26:6068-6076.
9. El-Sherbiny I.M., Lins R.J., Abdel-Bary E.M., Harding D.R.K. Preparation, characterization, swelling and in vitro drug release behaviour of poly[N-acryloylglycine-chitosan] interpolymeric pH and thermally-responsive hydrogels. European Polymer Journal 2005, 41:2584-2591.
10. Fejer I., Kata M., Eros I., Berkesi O., Dekany I. Release of cationic drugs from loaded clay minerals. Colloid & Polymer Science 2001, 279(12):1177-1182.
11. Granberg R.A., Rasmuson A.C. Solubility of paracetamol in pure solvents. Journal of Chemical & Engineering Data 1999, 44(6):1391-1395.
12. Güneri T., Arici M., Ertan G. Preparation and diffusional evaluation of sustained - release suppositories containing ibuprofen microspheres. FABAD Journal of Pharmaceutical Sciences 2004, 29:177-184.
13. Guyot M., Fawaz F. Design and in vitro evaluation of adhesive matrix for transdermal delivery of propranolol. International Journal of Pharmaceutics 2000, 204:171-182.
14. Hamza M., Dionne R.A. Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition. Current Molecular Pharmacology 2009, 2(1):1-14.
15. Higuchi T.J. Rate of release of medicaments from ointment bases containing drugs in suspension. Journal of Pharmaceutical Sciences 1961, 50:874-875.
16. Nanoclays, Technical Physical Properties Bulletin. http://www.nanoclay.com/product_bulletins.asp.
17. Hua S., Yang H., Wang A. A pH-sensitive nanocomposite microsphere based on chitosan and montmorillonite with in vitro reduction of the burst release effect. Drug Development and Industrial Pharmacy 2010, 36(9):1106-1114.
18. Huang X., Brazel C.S. On the importance and mechanisms of burst release in matrix-controlled drug delivery system. Journal of Controlled Release 2001, 73:121-136.
19. Hule R.A., Pochan D.J. Polymer nanocomposites for biomedical applications. MRS Bulletin 2007, 32:354-358. http://www.mrs.org/bulletin.
20. Joshi G.V., Kevadiya B.D., Patel H.A., Bajaj H.C., Jasra R.V. Montmorillonite as a drug delivery system: intercalation and in vitro release of timolol maleate. International Journal of Pharmaceutics 2009, 374:53-57.
21. 6 hybrids. Colloid & Polymer Science 2009, 287:1071-1076.
22. 1 as drug carrier. Applied Clay Science 2009, 45:248-253.
23. Katti K.S., Katti D.R., Dash R. Synthesis and characterization of a novel chitosan/montmorillonite/hydroxyapatite nanocomposite for bone tissue engineering. Biomedical Materials 2008, 3(3):034122.
24. Kevadiya B.D., Joshi G.V., Bajaj H.C. Layered bionanocomposites as carrier for procainamide. International Journal of Pharmaceutics 2010, 388(1-2):280-286.
25. Kevadiya B.D., Joshi G.V., Mody H.M., Bajaj H.C. Biopolymer-clay hydrogel composites as drug carrier: host-guest intercalation and in vitro release study of lidocaine hydrochloride. Applied Clay Science 2011, 52(4):364-367.
26. Korsmeyer R.W., Gurny R., Doelker E., Buri P., Peppas N.A. Mechanism of solute release from porous hydrophilic polymers. International Journal of Pharmaceutics 1983, 15(1):25-35.
27. Kubo W., Miyazaki S., Attwood D. Oral sustained delivery of paracetamol from in situ-gelling gellan and sodium alginate formulations. International Journal of Pharmaceutics 2003, 258:55-64.
28. Lee W.F., Chen Y.C. Effect of bentonite on the physical properties and drug-release behavior of poly (AA-co-PEGMEA)/bentonite nanocomposite hydrogels for mucoadhesive. Journal of Applied Polymer Science 2004, 91:2934-2941.
29. Lee W.F., Fu Y.T. Effect of montmorillonite on the swelling behavior and drug-release behavior of nanocomposite hydrogels. Journal of Applied Polymer Science 2003, 89:3652-3660.
30. Lee S., Kim M.S., Kim J.S., Park H.J., Woo J.S., Lee B.C., Hwang S.J.J. Controlled delivery of a hydrophilic drug from a biodegradable microsphere system by supercritical anti-solvent precipitation technique. Microencapsulation 2006, 23(7):741-749.
31. Leuallen E.E., Osol A. The solubility of theophylline in aqueous amine solutions. Journal of the American Pharmaceutical Association 2006, 38(2):92-95.
32. Liang S., Liu L., Huang Q., Yam K.L. Unique rheological behavior of chitosan-modified nanoclay at highly hydrated state. The Journal of Physical Chemistry. B 2009, 113(17):5823-5828.
33. Lin C.C., Metters A.T. Hydrogels in controlled release formulations: network design and mathematical modeling. Advanced Drug Delivery Reviews 2006, 58:1379-1408.
34. Lin F.H., Lee Y.H., Jian C.H., Wong J.M., Shieh M.J., Wang C.Y. A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier. Biomaterials 2002, 23:1981-1987.
35. Liu K.H., Liu T.Y., Chen S.Y., Liu D.M. Drug release behaviour of chitosan-montmorillonite nanocomposite hydrogels following electrostimulation. Acta Biomaterialia 2008, 4(4):1038-1045.
36. Miller M.R., Megson I.L. Recent developments in nitric oxide donor drugs. British Journal of Pharmacology 2007, 151(3):305-321.
37. Murtaza G., Ahamd M., Akhtar N., Rasool F. A comparative study of various microencapsulation techniques: effect of polymer viscosity on microcapsule characteristics. Pakistan Journal of Pharmaceutical Sciences 2009, 22(3):291-300.
38. Nayak P.L., Sahoo D. Chitosan-alginate composites blended with cloisite 30B as a novel drug delivery system for anticancer drug paclitaxel. International Journal of Plastics Technology 2011, 10.1007/s12588-011-9000-6.
39. Nunes C.D., Vaz P.D., Fernandes A.C., Ferreira P., Romao C.C., Calhorda M.J. Loading and delivery of sertraline using inorganic micro and mesoporous materials. European Journal of Pharmaceutics and Biopharmaceutics 2007, 66:357-365.
40. Ogawa K., Yui T., Miya M. Dependence on the preparation procedure of polymorphism and crystallinity of chitosan membranes. Bioscience, Biotechnology, and Biochemistry 1992, 56:858-862.
41. Patel H.A., Shah S., Shah D.O., Joshi P.A. Sustained release of venlafaxine from venlafaxine-montmorillonite-polyvinylpyrrolidone composites. Applied Clay Science 2011, 51:126-130.
42. Peh K.K., Yuen K.H. Development and in vitro evaluation of a novel multiparticulate matrix controlled release formulation of theophylline. Drug Development and Industrial Pharmacy 1995, 21:1545-1555.
43. Peppas N.A., Sahlin J.J. A simple equation for the description of solute release III. Coupling of diffusion and relaxation. International Journal of Pharmaceutics 1989, 57:169-172.
44. Pradosh R.D., Rudra M.N., Anamika B., Nayak P.L. Gelatin blended with nanoparticle cloisite30B (Mt) for control drug delivery of anticancer drug paclitaxel. International Research Journal of Biochemistry and Bioinformatics 2011, 1(2):35-42.
45. Prescott L.F. Kinetics and metabolism of paracetamol and phenacetin. British Journal of Clinical Pharmacology 1980, 10:291S-298S.
46. Profire L., Cojocariu A., Oprea A.M., Lupuşoru C.E., Ghiciuc C.M., Dehelean C.A., Vasile C. Synthesis and characterization of new nitric oxide donor compounds based on theophylline and paracetamol. Revista de Chimie (Bucharest) 2010, 61(12):1150-1154.
47. Rao P.R., Reddy M.N., Ramakrishna S., Diwan P.V. Comparative in vivo evaluation of propranolol hydrochloride after oral and transdermal administration in rabbits. European Journal of Pharmaceutics and Biopharmaceutics 2003, 56:81-85.
48. Ray S.S., Bousmina M. Biodegradable polymers and their layered silicate nanocomposites. In greening the 21st century materials world Progress. Materials Science 2005, 50:962-1079.
49. Razzak M.S.M.I., Khan F., Khan M.Z.R., Fatema K., Islam M.S., Reza M.S. Effect of channeling agents on the release profile of theophylline from Methocel K4M based matrix tablets. Journal of Pharmaceutical Sciences 2008, 7(1):27-32.
50. Reza M.S., Quadir M.A., Haider S.S. Development of theophylline sustained release dosage form based on Kollidon Sr. Pakistan Journal of Pharmaceutical Sciences 2002, 15(1):63-70.
51. Ritger P.L., Peppas N.A. A simple equation for description of solute release. I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. Journal of Controlled Release 1987, 5:23-36.
52. Rottier B.L., Duiverman E. Anti-inflammatory drug therapy in asthma. Paediatric Respiratory Reviews 2009, 10(4):214-219.
53. Shin-Ya Y., Tsurushima H., Tsurumi T., Kajiuchi T., Leong K.W. Polyelectrolyte complex films derived from polyethyleneoxide-maleic acid copolymer and chitosan: preparation and characterization. Macromolecular Bioscience 2004, 4:526-531.
54. Simpson J.L., Phipps S., Gibson P.G. Inflammatory mechanisms and treatment of obstructive airway diseases with neutrophilic bronchitis. Pharmacology and Therapeutics 2009, 124(1):86-95.
55. Singh S.K., Pandit J.K., Mishra D.N. Influence of drug solubility, drug polymer ratio, nature of coexcipients and thermal treatment on drug release from carbopol. Acta Pharmaceutica Sciencia 2006, 48:167-178.
56. Takahashi T., Yamada Y., Kataoka K., Nagasaki Y. Preparation of a novel PEG-clay hybrid as a DDS material: dispersion stability and sustained release profiles. Journal of Controlled Release 2005, 107:408-416.
57. Talukder M.M., Michoel A., Rombaut P., Kinget R. Comparative study on xanthan gum and hydroxypropylmethylcellulose as matrices for controlled-release drug delivery I. Compaction and in vitro drug release behaviour. International Journal of Pharmaceutics 1996, 129:231-241.
58. Thapa N., Stevens H.N.E., Baillie A.J. In vitro drug release studies from a novel lyophilized nasal dosage form. Journal of Science, Engineering and Technology 2009, 5(1):71-86.
59. Wu C.-J., Gaharwar A.K., Schexnailder P.J., Schmidt G. Development of biomedical polymer-silicate nanocomposites: a materials science perspective. Materials 2010, 3(5):2986-3005.
60. Xiaoying W., Yumin D., Jiwen L. Biopolymer/montmorillonite nanocomposite: preparation, drug-controlled release property and cytotoxicity. Nanotechnology 2008, 19(6):065707.
61. Xu R., Manias E., Snyder A.J., Runt J. Low permeability biomedical polyurethane nanocomposites. Journal of Biomedical Materials Research 2003, 64A:114-119.
62. Yang S.H.H., Wang W., Wang A. Controlled release of ofloxacin from chitosan-montmorillonite hydrogel. Applied Clay Science 2010, 50(1):112-117.
63. Yano K., Usuki A., Okada A. Synthesis and properties of polyimide-clay hybrid films. Journal of Polymer Science Part A: Polymer Chemistry 1997, 35:2289-2294.
64. Zheng J.P., Luan L., Wang H.Y., Xi L.F., Yao K.D. Study on ibuprofen/montmorillonite intercalation composites as drug release system. Applied Clay Science 2007, 36:297-301.